RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT07819643

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Keqiang Zhao (from the registry)
Registry
  • NCT NCT07819643
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07819643. Randomized; single masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Acronym
RESCUE
Condition
Atherosclerosis Cerebral
Condition
Carotid Plaque
Condition
Vulnerable Plaque
Condition
Carotid Stenosis
Intervention (Drug)
Intervention 1
Intervention (Drug)
Intervention 3
Intervention (Drug)
Intervention 2
Intervention (Drug)
Intervention 4
Lead sponsor
Keqiang Zhao (class: other)

Record details

Record id
cardio:ct-nct07819643
Content hash
4ced60c6d9f882a5a9e8bf32b63c48d1c2cf49b91e0668b0085ae708eaf4e580